09:48 AM EDT, 10/01/2024 (MT Newswires) -- Lexaria Bioscience ( LEXX ) said Tuesday that it has appointed Michael Shankman as chief financial officer, effective immediately.

Lexaria said Shankman previously worked with the company and assisted with its financial reporting and 2023 audit as a designated contractor.

Price: 3.04, Change: -0.01, Percent Change: -0.26